Matches in Nanopublications for { ?s ?p "[(2) SCN1A testing should be considered in people with possible DS where the typical initial presentation is of a developmentally normal infant presenting with recurrent, febrile or afebrile prolonged, hemiclonic seizures or generalized status epilepticus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP745425.RAv4T6zI76P2_MlOHcCTCqaLQHDt_JYfu7rsWtf7KweZw130_assertion description "[(2) SCN1A testing should be considered in people with possible DS where the typical initial presentation is of a developmentally normal infant presenting with recurrent, febrile or afebrile prolonged, hemiclonic seizures or generalized status epilepticus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP745425.RAv4T6zI76P2_MlOHcCTCqaLQHDt_JYfu7rsWtf7KweZw130_provenance.
- assertion description "[(2) SCN1A testing should be considered in people with possible DS where the typical initial presentation is of a developmentally normal infant presenting with recurrent, febrile or afebrile prolonged, hemiclonic seizures or generalized status epilepticus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[(2) SCN1A testing should be considered in people with possible DS where the typical initial presentation is of a developmentally normal infant presenting with recurrent, febrile or afebrile prolonged, hemiclonic seizures or generalized status epilepticus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP682444.RADWCMkKylroNy_MqoObZChlx2D47a5rq7SHONUHEjGTI130_assertion description "[(2) SCN1A testing should be considered in people with possible DS where the typical initial presentation is of a developmentally normal infant presenting with recurrent, febrile or afebrile prolonged, hemiclonic seizures or generalized status epilepticus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682444.RADWCMkKylroNy_MqoObZChlx2D47a5rq7SHONUHEjGTI130_provenance.
- NP682433.RANYSu9IUHDfN9lSUPdMHoOJ1SQHwVeDSLLUp9jgxYRvk130_assertion description "[(2) SCN1A testing should be considered in people with possible DS where the typical initial presentation is of a developmentally normal infant presenting with recurrent, febrile or afebrile prolonged, hemiclonic seizures or generalized status epilepticus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682433.RANYSu9IUHDfN9lSUPdMHoOJ1SQHwVeDSLLUp9jgxYRvk130_provenance.
- NP1069333.RAKwsVLsV58HGEMzlDwEBKH1DaLUYreRflXL3G23kerDE130_assertion description "[(2) SCN1A testing should be considered in people with possible DS where the typical initial presentation is of a developmentally normal infant presenting with recurrent, febrile or afebrile prolonged, hemiclonic seizures or generalized status epilepticus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069333.RAKwsVLsV58HGEMzlDwEBKH1DaLUYreRflXL3G23kerDE130_provenance.
- NP1069335.RA-nj1uX6TzXLvJ80ghOAkmF_68buZXYaXaB3IQd34nlQ130_assertion description "[(2) SCN1A testing should be considered in people with possible DS where the typical initial presentation is of a developmentally normal infant presenting with recurrent, febrile or afebrile prolonged, hemiclonic seizures or generalized status epilepticus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069335.RA-nj1uX6TzXLvJ80ghOAkmF_68buZXYaXaB3IQd34nlQ130_provenance.